Despite increasing recognition that there is a neurobiological basis of antisocial behavior in
addition to its psychosocial foundation, much less is known about the specificity of the …

Health economics evidence informs health-care decision making, but the field has
historically paid insufficient attention to mental health. Economic evaluations in health …

Background Severe self-harm leading to extensive hospitalization generates extreme
challenges for patients, families, and health services. Controversies regarding diagnoses …

Objective Evidence-based personality disorder (PD) treatments are dominated by
interventions targeting Borderline PD, although clinical populations characteristically include …

Background Employees' health conditions are issues for not only employees themselves but
also companies and society to keep medical costs low and productivity high. Data and …

Personality disorders (PDs) are associated with high levels of societal costs, regardless of
whether a single PD or a broad range of PDs have been studied. However, research on the …

Background Borderline personality disorder (BPD) is a serious disorder with a lifetime
prevalence of 2.7–5.9% and is thought to correlate with altered neuroplasticity. The aim of …

Personality disorders (PDs) are associated with high levels of societal costs. However,
previous research has found limited or no evidence of unique contributions of individual PD …

There is currently insufficient evidence for the use of a specific pharmacological treatment for
personality disorders (PD). The research literature lacks a systematic exploration of …

Health economics informs decision-making by healthcare regulators and government
bodies but has historically paid insufficient attention to mental health. Economic evaluations …